<SEC-DOCUMENT>0000950103-13-005696.txt : 20131001
<SEC-HEADER>0000950103-13-005696.hdr.sgml : 20131001
<ACCEPTANCE-DATETIME>20130930194612
ACCESSION NUMBER:		0000950103-13-005696
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20130930
FILED AS OF DATE:		20131001
DATE AS OF CHANGE:		20130930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ULTRAPAR HOLDINGS INC
		CENTRAL INDEX KEY:			0001094972
		STANDARD INDUSTRIAL CLASSIFICATION:	NATURAL GAS DISTRIBUTION [4924]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14950
		FILM NUMBER:		131124799

	BUSINESS ADDRESS:	
		STREET 1:		AV BRIGADERIO LUIZ ANTONIO 1343
		STREET 2:		9 ANDAR SAO PAULO
		CITY:			SP BRAZIL 01350-900
		STATE:			D5
		ZIP:			00000

	MAIL ADDRESS:	
		STREET 1:		CT CORPORATION SYSTEM
		STREET 2:		1633 BROADWAY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>dp40981_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html>
<head>
    <title></title>
</head>
<body bgcolor="#ffffff" style="TEXT-INDENT: 0pt; DISPLAY: inline; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5%; FONT-SIZE: 10pt; MARGIN-RIGHT: 5%">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">Form 6-K</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">Washington, D.C.&#160;&#160;20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">Report Of Foreign Private Issuer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">Pursuant To Rule 13a-16 Or 15d-16 Of</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">The Securities Exchange Act Of 1934</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the month of September, 2013</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Commission File Number: 001-14950</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">ULTRAPAR HOLDINGS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Translation of Registrant&#8217;s Name into English) </font>

<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Avenida Brigadeiro Luis Antonio, 1343, 9&#186;</font> <font style="DISPLAY: inline; FONT-WEIGHT: bold">Andar</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">S&#227;o Paulo, SP, Brazil&#160;&#160;01317-910</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Address of Principal Executive Offices) </font>

<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="40%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="12%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form 20-F</font></div>
</td>
<td valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">X</font></div>
</div>
</td>
<td valign="top" width="7%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
<td valign="top" width="12%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form 40-F</font></div>
</td>
<td valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="40%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="12%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yes</font></div>
</td>
<td valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
<td valign="top" width="7%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
<td valign="top" width="12%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">No</font></div>
</td>
<td valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">X</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="40%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="12%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yes</font></div>
</td>
<td valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
<td valign="top" width="7%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
<td valign="top" width="12%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">No</font></div>
</td>
<td valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">X</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ULTRAPAR HOLDINGS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TABLE OF CONTENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM</font></div>
</td>
<td valign="top" width="73%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="73%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Material Notice</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td valign="top" width="8%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td align="left" valign="top" width="73%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Board of Directors Minutes dated September 18, 2013</font></div>
</td>
</tr></table>
</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><img src="logo.jpg"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ULTRAPAR PARTICIPA&#199;&#213;ES S.A.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Publicly Listed Company</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">CNPJ n&#186; 33.256.439/0001- 39</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">NIRE 35.300.109.724</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">MATERIAL NOTICE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ULTRAPAR ENTERS INTO AN ASSOCIATION AGREEMENT WITH EXTRAFARMA TO ENTER THE BRAZILIAN RETAIL PHARMACY SECTOR</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">S&#227;o Paulo, September 30, 2013 &#8211; Ultrapar Participa&#231;&#245;es S.A. (&#8220;Ultrapar&#8221;) informs that it entered today into an association agreement with Imifarma Produtos Farmac&#234;uticos e Cosm&#233;ticos S.A., one of Brazil&#8217;s ten largest drugstore chains, which operates under the brand Extrafarma (&#8220;Extrafarma&#8221;). According to the terms of the agreement, Ultrapar and Extrafarma will enter into an <font style="FONT-STYLE: italic; DISPLAY: inline">incorpora&#231;&#227;o de a&#231;&#245;es</font> (merger of shares), pursuant to which Ultrapar will acquire 100% of the shares of Extrafarma in exchange for up to 2.9% of shares to be issued by Ultrapar to Extrafarma&#8217;s shareholders (the &#8220;Transaction&#8221;). As a result of the Transaction, Extrafarma will become a wholly-owned subsidiary of Ultrapar. The total amount of the Transaction is R$ 1,006 million, consisting of the issuance of up to 16,028,131 shares of Ultrapar and the assumption by Ultrapar of Extrafarma&#8217;s net debt of R$ 106 million as of December 31, 2012. This amount is subject to working capital and net debt adjustments as of the closing date of the Transaction.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">The association with Extrafarma and its management team marks Ultrapar&#8217;s entry into Brazil's significant, growing retail pharmacy sector. This move opens new opportunities for value creation, mainly through the enhanced scale for the expansion of Extrafarma&#8217;s stores, to be boosted by increased investment capacity, by the widespread presence of Ipiranga&#8217;s service stations and Ultragaz&#8217;s resellers, and by the implementation of Ultrapar&#8217;s corporate governance and incentive systems.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Extrafarma will become Ultrapar&#8217;s third specialized distribution and retail business, with characteristics of growth, resilience, and differentiation in services and convenience to customers.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">I. MOTIVATION AND STRATEGIC RATIONALE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Significant market, with strong potential for growth and consolidation</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Brazilian drugstores&#8217; total revenues, according to IMS Health e ABIHPEC data, exceeded R$ 60 billion in 2012, with real growth rate of over 10% per year in the last years, and are expected to continue this path of significant growth, mainly due to (i) the aging population; (ii) increasing consumer income; (iii) greater access to medicines, especially due to the growing participation of generic drugs; and (iv) growing demand for personal care and beauty products. In addition, the consolidation of the sector, leveraged by increasing</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">formalization and the consequent investments, is in its initial stage, with the top ten chains in Brazil accounting for only 35% of the medicine market.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Extrafarma is one of the leaders in regions of higher growth</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">With over 50 years of activity in pharmaceutical distribution, Extrafarma has 186 drugstores in the North and Northeast regions of Brazil, and is one of the leaders in its region. Extrafarma operates in areas where recent growth rates are above the national average and that present attractive potential for future growth, in addition to counting on renowned and recognized professionals in the sector. For 2013, Extrafarma estimates to present gross revenues of R$ 1 billion and EBITDA of R$ 77 million. Further information on Extrafarma is available at </font><font style="DISPLAY: inline; COLOR: #0000ff; FONT-SIZE: 10pt; TEXT-DECORATION: underline">www.ultra.com.br</font><font style="DISPLAY: inline; COLOR: #0000ff; FONT-SIZE: 10pt; TEXT-DECORATION: underline">.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Ultrapar strengthens and accelerates the expansion of the Extrafarma chain</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">The association with Ultrapar will allow the acceleration of Extrafarma&#8217;s expansion plan through (i) increased investment capacity, (ii) access for drugstore openings in Ipiranga&#8217;s service stations and Ultragaz&#8217;s resellers, with over 10 thousand retail outlets; and (iii) the strengthening of Extrafarma&#8217;s experienced retail pharmacy management team, by implementing Ultrapar&#8217;s recognized mechanisms of corporate governance, incentives, and alignment of interests. These mechanisms are also expected to contribute to an efficient integration of the operations and to the development of business models that are increasingly attractive to Extrafarma&#8217;s, Ipiranga&#8217;s and Ultragaz&#8217;s consumers, thus increasing these businesses&#8217; differentiation potential.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">II. STRUCTURE OF THE TRANSACTION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">The association will be effected as <font style="FONT-STYLE: italic; DISPLAY: inline">incorpora&#231;&#227;o de a&#231;&#245;es</font> (merger of shares), pursuant to which Ultrapar will acquire from the current seven shareholders of Extrafarma (who are the heirs of the company&#8217;s founder) all of the shares of Extrafarma in exchange for up to 16,028,131 newly issued shares of Ultrapar, in accordance with Art. 252 of Brazilian Corporate Law 6,404/76.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">As a result of the Transaction, Extrafarma will become a wholly-owned subsidiary of Ultrapar, and the current shareholders of Extrafarma will become long-term shareholders of Ultrapar, with an ownership interest of up to 2.9% of Ultrapar&#8217;s total capital, which evidences their confidence in the growth potential of the sector and in the project to be developed by Ultrapar and Extrafarma. Mr. Paulo Correa Lazera, Extrafarma&#8217;s shareholder and CEO, will remain in charge of the retail pharmacy business as its Chief Executive Officer and will become a member of Ultrapar&#8217;s executive board.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">After the customary conditions precedent for this type of transaction are met, particularly the approval of the Transaction by the Brazilian antitrust authority, the Transaction will close on the date it is approved by extraordinary general shareholders&#8217; meetings of both companies (&#8220;Closing&#8221;), which are expected to take place in early 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Ultrapar&#8217;s shares to be issued and transferred to the current shareholders of Extrafarma will be subject to lock-up agreements and will become available for trading in phases, being 33.5% immediately available for trading after the Closing, and the remaining shares</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">will be unlocked in five annual tranches of 8.3%, and a final tranche of 25% in the sixth year after the Closing.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">As a mechanism for possible adjustments related to working capital, net debt as well as contingencies whose triggering event occurred prior to the Closing, it has been established that the last 25% of Ultrapar&#8217;s shares to be issued to Extrafarma shareholders will be delivered in the form of subscription warrants, which may be reduced as a result of these adjustment factors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">III. GENERAL PROVISIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">CADE.</font> The completion of the Transaction is subject to approval by the Brazilian Antitrust Authority (<font style="FONT-STYLE: italic; DISPLAY: inline">Conselho Administrativo de Defesa Econ&#244;mica</font> &#8211; CADE) and will be submitted to it according to the prevailing legislation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">General Meeting.</font> After being approved by CADE, the Transaction will be submitted to Ultrapar&#8217;s and Extrafarma&#8217;s extraordinary general shareholders&#8217; meetings pursuant to Art. 252 of Brazilian Corporate Law 6,404/76. The documents required for the approval of the Transaction will be timely made available to the shareholders. Under the current dispersion and liquidity conditions of Ultrapar&#8217;s shares, the Transaction will not trigger withdrawal rights to Ultrapar&#8217;s dissenting shareholders, as set forth in Art. 252, paragraph 1, combined with Art. 137, item II, both of Brazilian Corporate&#160;Law 6,404/76.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Future communications.</font> Ultrapar&#8217;s management will keep the market and its shareholders informed about the progress of the Transaction described herein, including the information set forth in CVM Instruction No.&#160;319/99 and other applicable rules.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Andr&#233; Covre</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Chief Financial and Investor Relations Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Ultrapar Participa&#231;&#245;es S.A.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 2</font></div>

<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ULTRAPAR PARTICIPA&#199;&#213;ES S.A.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Publicly Traded Company</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">CNPJ n&#186; 33.256.439/0001- 39</font></div>
</td>
<td valign="top" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 10pt">NIRE 35.300.109.724</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">MINUTES OF THE MEETING OF THE BOARD OF DIRECTORS (08/2013)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Date, Time and Location</font>:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">September 18<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font>, 2013, at 12:00 p.m., at the Company&#8217;s headquarters, located at Av. Brigadeiro Lu&#237;s Ant&#244;nio, n<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">r</font> 1343, 9<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> floor, in the City and State of S&#227;o Paulo.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Attendance</font>:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Members of the Board of Directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Decision</font>:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">After the presentation regarding the acquisition of Imifarma Produtos Farmac&#234;uticos e Cosm&#233;ticos S.A. (CNPJ/MF n&#186; 04.899.316/0001-18) (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Imifarma</font>&#8221;) by the Company, as conducted and proposed by the Officers, the Board Members present decided, by unanimous votes and with unqualified opinion, (i) to approve the aforementioned acquisition through incorporation, by the Company, of 100% of the shares of Imifarma, (ii) to authorize the signing of the Association Agreement by the Officers of the Company and by the shareholders of Imifarma, and (iii) to authorize the Officers to perform all acts and contracts necessary to implement such operation, having decided that the signing of the Association Agreement is subject to the satisfactory result, to the Officers and to its external advisors, of the negotiation of the transaction documents, in accordance with the presentation made <font style="DISPLAY: inline; FONT-FAMILY: Arial">&#8203;&#8203;</font>to this Board of Directors. The conclusion of the</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 8pt">(Minutes of the Meeting of the Board of Directors of Ultrapar Participa&#231;&#245;es S.A., held on September</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 8pt">18<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font>, 2013)</font></div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">transaction is subject, among others, to the approval by the antitrust authorities and by the shareholders of the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Observation: The deliberation was approved, with no amendments or qualifications, by all the Board Members present.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">As there were no further matters to be discussed, the meeting was closed, and the minutes of this meeting were written, read and approved by all the undersigned Board Members present.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Paulo Guilherme Aguiar Cunha</font> &#8211; Chairman</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Lucio de Castro Andrade Filho </font>&#8211; Vice Chairman</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ivan de Souza Monteiro</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Nildemar Secches</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Olavo Egydio Monteiro de Carvalho</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Paulo Vieira Belotti</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pedro Wongtschowski</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 8pt">(Minutes of the Meeting of the Board of Directors of Ultrapar Participa&#231;&#245;es S.A., held on September</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 8pt">18<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font>, 2013)</font></div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Renato Ochman</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date: September 30, 2013</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="right">
<table cellpadding="0" cellspacing="0" width="50%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" colspan="3" valign="top" width="72%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ULTRAPAR HOLDINGS INC.</font></div>

<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="8%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By:</font></div>
</td>
<td align="left" colspan="2" valign="top" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Andr&#233; Covre</font></div>
</td>
<td valign="top" width="28%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
<td align="left" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name:</font></div>
</td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Andr&#233; Covre</font></div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
<td align="left" valign="top" width="14%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title:</font></div>
</td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial and Investor Relations Officer</font></div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: arial; FONT-SIZE: 8pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Material Notice; Board of Directors Minutes dated September 18, 2013)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@,"
M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`$<`2P,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/W\H`0G'^?6C;RM^`;=-A,XZ#\N/_U4MNE@V_JQ\O?%/XV_
M&'PS=76F?##]F7QY\1KBW:2)=:OM>\*>$_#LDBMM$EL;K5+C4+N`\D,;.WR.
MAP<U]#EF4Y9B(J>89[0R^'\BA4JU/FDE&/\`X$SR\5C<92<H87+JE=QVDY1A
M#Y;O\$?*NI?'W_@I5-<$Z-^RCX#TVUR=L&IWTNLS@$C;NN;7XD:4G'.3Y'.>
MV.?J:62>'L8+V_$F*E.U[TU&"3_PRPLWK_B/)GF'$G,E2RNG"/\`?C)V^:KI
M?.QVFB?'O]O31]06T\;_`+(.A>(;6/R3->^`_'6EZ6K+)$CLUJ-7UW58Y&5F
M8%&F7!!7<<;FX:N3<&5*;E@N):N&DMHXFBYOYNG2I6^XZ*>/SR$E&ME49+O3
MDHI??4G^A]L?#WQIK'C/2#>Z[\/?%WPXU2#RUN=$\5KH\LF]PQ)LK_0]4O;:
M]@4K@ONB;D9C&17R&-PM+!U>2CC*6-I?9G2YU_X%&<8N+\K/U/;P]6=6'-.A
M/#2_EG;\XMGH`_SVKB73IY?U:QOZ:6%I@%`"?3CT[8HV^70/Z^\X+X@?$[P!
M\*M)M]:^(7B_0?!VF7EX-.L;S7KY+*&ZOWADG6U@!R\K^7$[ML4[57)QD9Z\
M#E^-S&K*C@<+4Q-2$>9QIQORQO9OM]_4PQ&)P^#@I8BK&A%Z)R=DW_6Y^._Q
M4U;4?BCXPU'Q3-_P4B^'_A"SFD>+2?#'@Z?Q-H6B:+IHD9K>SCAL-<A:^N%1
MAYEY<[YI6R257:B?JN5TH99A*=#_`%!Q&+G%>_6K*G.<Y6U?O1?*NT8V21\=
MBJCQ-653_6&E1C]F,'4A%+HO=:7KNV[ZGG'_``AUQ_TE$T?_`,*/QM_\TM>B
ML5!6_P"-<25O^G='_P"5G-[/MQ-'_P`#K?\`R0'PC:1@MK'_``5!M9-)`VZC
M%IFL>-KV_DM)2(Y8[2T_X20^?,RO@+@CDLWR@U+Q3M:CX<VK?8YH48KFWU:@
MK(%22^+B5<O6TZU[>2YB&W\`VVF0QV&D_P#!3S1;33+,>186R:]XS@6"TC)$
M$8BB\3%(\1[1M3Y1T'&*MXUM\U7PYDZCUD_9T6G+JU>F"HJ.D.)8I=%S55I\
MI$W_``AUQ_TE$T?_`,*/QL/_`'9:2Q4+_P#)MY?^"Z*_]QB]C;1<2Q_\#K?_
M`"1]O?LT?'/PE\,-.F\(?$[]LSX6?%S3))(E\-:A=37]EXITVXGF5&L+S6-0
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MU=1E)Q=N6^U[7\SXK,<RRO%5W#$8.O45"\(N,U".^KY;K?NSYX_X3/\`X)]C
M_FVGXZ\=O^$OOQU_[F*O?6"XZ7_-2X'3_IW#3_RF>?[3(?\`H78C_P`&+_Y(
M3_A,_P#@GV/^;:?CJ,?]3??C&?\`N8J?U+CI?\U)@E_W#A_\@'M,A6V78A?]
MQ%_\D7+;QE^P?$DUYI_[)_QMU6UMP(=6FO/%6K/:Z597JR6RZ@&BUF1%O%N6
MA6!96@4N^1)N0*^4L'QJI1C/BG!4I2UA^[@FVM;+W.V]KCC5R2-Y0RO$-+>]
M31?<[?>4_P#A,_\`@GV.!^S3\=>/^IOO_P#YHJT6#XZZ<28)>7LX?_("]ID*
M_P"9;B-/^GB_^2#_`(3/_@GW_P!&T_'7_P`*^_\`_FBH^I<=?]%)@K?]>X?_
M`"`>TR'_`*%V(_\`!B_^2%_X3/\`X)]?]&T?'3'3'_"7W_\`+_A(J'@N.K6_
MUDP7_@N"W_[<#VN0K_F78A6_Z>6_]N/V+_8V^.OPY^+O@"Z\/?#S1?&?AJQ^
M&/\`9GAU=(\=WC:CK@TNXMI9M)N5U*6[N);^T"0W%JK2RLZ"R"'C:3^4\49+
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M2Z_WGKY:'O7P[^(?[6OQ9_97\&_$3P%I?PSN_BKXJ\5ZE</)K.EPZ-X>L_`U
MC=:C80F.QDN9#/J,UU9Q,)!*/DE8[?EY\3'X#AK*N),5@,97Q<<LPU**7LYN
M=5UY)2MS*.D4G9Z;GI8;$9GBLLHXBA3I?6*DY7YDHQ5-76G2\FON?S/E_P`)
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M8BV`2:.,<FHY%FRPF%E4EA94:=6FZDN=^]=2ULNL>W4>1XZ>.P;K58QC5C.4
M9<JY=M5IIM<^RJ^4/9/EK]MCQ5=>#/V5OC5K5GYHN9/"B>'XFA'SPGQ?J^F>
M$FGX^ZD2:VTC-V6-CVKZ3A#"QQ?$F4T)6456=37;]S3G6M_V][.WS/+SJJ\/
ME6,G&_P*&FZ524:;MYVDV?,?_!,>W\.>#/V7M?\`&=_JFGVBW_C'Q-J_B"YF
MNH(1IMEH%I:6,"7K.X\G%O:S7`WE<K=*PX;GZ#Q$>(Q?$E+!QHSE[&C2ITDD
M[-S;E>-MU=J+MV\CRN&/8T,KJ5G.,7*I.4[M*R225^W5KU/QK\4:_>>(M`^,
M'Q#F4O=_%;XKIIME(V1)-;QWNJ^-=9CB/\21SW7A.-@.!YJ#C@']:PE&&'K9
M3E\;)97@?:323T;C&E#1;-\LW]Y\;5FYPQ==W;Q5>R>SU;F_Q:]-#^FKX-Z1
MI'PN^"/P^\,RW=G!'X0^'^C1WZBX@4K<6FD1WFJ,5#_>-TUTQXY))K^=\TE7
MS#.,;B/9S_VK$SL^5[2G:/3M9'Z;@E3PF!P]+FC'V5*-]5ORW>WG<_-__@F1
M8S^,_B/^TE\;[X%YM?\`$":7:3N,DMKNL:GXGU%48_W8QI2GVQVK[_Q#E'!9
M?P]D]-<GL*//-+IR0C3CIYMS_,^;X8A[3$YCC6[\TN5/_%)R?X)?(^>_!WA7
MXS?M'?MD_'SQU\#_`(@Z9\/-=\+:OK$=MXLU2WFNXDT/[9_PB%GIUDD5A>+Y
MUQ8::[[FC4>7$^&!;GW,3BLIX>X2R3`YQ@)8ZCB8PDZ4&HM3<?:RE*\H[2EI
MKU."A2Q>89UCJV#KK#SI.7O-V]V_(E\,NGD;GACP3X]\2_MR>%O@Q^UGXLN/
MC4OA73;K6=,D36)+/PQ9.NA1^*K*_?2X[2S0VC+:)'>6LD432E4,CR1(`^6(
MQ>"PW!N)S;A?"+)_K4E3J+EO4:<W3<8SO)WUO%J32OHKFE.C7GGE+!YI5^LJ
MC%RC[SY%[O,F](V_O64;]3EOBK\?;7XR?M<6/Q(N?AUXY^*_P;^#.I-H_A;P
MSX*TJ74;74KK2I)I[35;YOLDMK'::AKD4=\\<@#SVEA:0\H#CIRW))Y-PK4P
M-/'8?+,XS://5J5ZG(X0G:\%LU*--\J:VFVS'%8Z.-S=5I4)U\%@Y<L(P3L^
M6]MD[<TM=.FA]7?\$PO%T5_K_P"TSX:&FZGH`?QUI_C2Q\/ZRAM]4T>VUV;6
M[6>QOK<HGE7<'V.RBE`10&7H,BOFO$3!NC0X>Q"J0JJ.&>'E4IOFA.5-0?-&
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MA\>?%SPSX?\`A_::M'IMKH/AR]2XU34M=N+6XU?7M>O-0\-W4E_K%R;&S0R*
M842.W2..-4557BP=#Q$P>)QF+6!PM:OC7!R=2I%J$:::A3IJ-:*C!7;MK=N[
M9K6?#=6G0I*M7I0PZ:2A3MS.6KE*\'[W9JUEIL<18:3_`,$U](O(=1M?C!^T
M%)<6JS/"DNCLR^8\$L08*?",8\Q?,W(68*'52W`(/5/_`(B!.#I_V-EM.+^)
MQ<%^/MG;77179G&'#T/AQ>*OY12?HK06_P#6A]5?L]?M6_L.?L^_#K4/`_@K
MQI\2X+;7M1O-=O;GQ'X4N[[7[34-1T^UL3"]UI.F1V4GV6.UC\ORUD7=N.YP
M:^;SOACC3.\=3QN*P>&E.A"-.*I58JDXQ;=[2J.7O-OFNU?R/3P&9Y+E^'G0
MHU:R4VY-RI^\FU;[*4=/)&?^SO\`M&_L&_LU#QB_@SX@_$W6+KQO>6%[K%]X
MH\*:C>72OIXO#'';/I^A6:I$\M_<2.'5R68'('%:9YP_QOG_`-56+R_#4HX.
M+A3C1JPBK/EO=2J2UM%;6)R[,,BRWVKHUZTG6:YN>F^E^T5W\SDO'_QB_8-\
M??%?Q)\8Y?B]\:/#OB_Q-X<G\+7K>'O#5Q;6=KI=WX>_X1B]_L]+OPQ<36UU
M-I1D0RF=]K3,R@<`=6!RGCC`Y;0RF.4X*MA*%7VL55J1;<U4]K'FM6BFE+6W
M*C'$8K(J^*GBOK>(IU:D7%\D+*TH\KWC?;S/5_@'^UQ^PE^SGX&'@/P'XM\;
MS6$FJWFLW^IZSX-UBXUC5+^]$4?FWUQ::5;1NL-K!;V\2K$@6.`<%F8MYN=<
M+<;9[C/KF,P=&-10C",*=>G&G",;Z13J.UVVWKOU.O+\TR3+:/L*%6I9R<I2
ME3=VWWLDO2R/;/V49?V>OB+\9/C3\=O@EXE^(&K:OXIAL['QS8:]I3Z5X3MK
MS5;FWU&R;2$N=)M[AM00Z1=.5-U.$3492P'F1[?'XD6?Y=E64Y+G&'P]&CAK
MRPSIR4JSC#FB^=QG)*/[Q?9C=Q79G=E;P%?%XO'8.I5E*HK3C*/+!.33NM$[
M^YIJ[*_<_0*OB3WA#TQT_3%)[:.W8/(_-S]K7PR?AQJNF^+O`O[&WPO^.-KX
MKN[QO$VH+X5-YXKL?$,KO<M>:G;:?I%R]W97D>]OMAY6:-EEP94+?>\+XAXV
M$\)B^*\7DKPZBJ,55<:,J:T:BY5(J,D]H[6VN?.9M1CAYQJTLGHXQ5+\S<+S
M4_.T7HUU/C?_`(6/XS'_`#B]\&C_`+IUK(_]U>OKEEV$7_-QZ_\`X4)6\OXI
MXWMY[?ZM4O\`P3/_`.0)[?XA_$IV=]"_X)B^"+/5;6*2]L[N?X;ZK+%:/:#S
MS<M;RZ#;K<%%5BL0E5F;:%#'Y6BIE^7I)5O$3$3IR=I16)2NGTTJ.UV^UAJM
M5VAPW2C):I^QEIWT<%<CD^)GC>62267_`()?^#FEE=Y9'/PZUD%I)&+NY'_"
M+\;F)./>KCEN#@E&/B-7C%;)8F.BZ+^*)UZG7AJE?_KS/_Y`C_X61XS'_.+W
MP;_X;O6?_F7I_P!G83_HX]?_`,*8_P#RT/;S_P"B:I+_`+@S_P#D`_X61XS'
M_.+WP;Q_U3O61U_[E>C^SL)_T<>NO^YF/_RT/;S7_--4E_W!G_\`(#T^(GC5
MW2-/^"7O@S=(ZH@;X>ZQ&-[,%4%W\,JJ`L1\S$`=2<5+R_")/_C8U>T=7_M"
MV\E[7?R&J]31?ZMTHW:WI26__;B/V/\`@IX+LO!?@/1X5^'G@OX8Z[K%K;ZQ
MXJ\,>!+2&VT2SURXA020">*VA-_/;VZP6[SLGS-"VSY-M?E&;8J>*QM;_;J^
M/I4Y.%&MB)-S=-/>S;Y5)W:5]K=;GV&"H1H4()8>&%G))SA3TBGVZ7T/6Z\T
MZP_SZ4>6P;>5B.1`T;H2ZAT9"T;M&ZA@02CH04<=B.0<$4+W6FK)+OM]P6TL
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M#^/^HE`.OT>G_:W":T7!-?[Y?YC6%S+_`*'=-?\`<3_@!_PIC]KL?\Y#/!ZX
M_P"HG`.O_`^*/[6X3_Z(FO\`^3+]0^K9DM/[:I_^#+?H:VD_L\_MLZ[YW]A?
MMY:+K`MBHN#I)EU'[.SYV";[&DGE%L'&[&<'%93SO@ZE:-3@^I2ET4I<OYR3
M+C@<WE_#S:,DOY9O](GVE^SS\(?BK\-=/U"Z^+WQP\3_`!>\3ZC^Y2*Y*V7A
M;1+2.0O&-,T_R5GN+^0!?-NKB3@?)'&@RS_)YWF.68VK365933RO#4UT;E5F
MWNY.[27917G<];`X7$X:+>*Q<L14>B5WRQ7=)[M][)>5]3Z6Z?YQ7AVMMI8]
M#;RL%`!0`?Y]*`_KL)@#MBBU@VVTM\CP'XI_LN?`?XR>;-X[^&_AR_U648/B
M"TTZUTWQ#UW'=JUI"L\I[9E,F!TQ7KY=GV;Y3[N!QU2C3_Y]MJ5->D)IQ7R2
M9Q8C+L'B7>K07-MS1O"6OG&S^\^2]2_X)0_LR7T[2VFK?%718RS-]ETSQ)X:
MDMQNQA5_M?P7?2A5P<?O?XCDGC'U5#Q*XAHQY94<%B'I9U*$U)6_Z]UJ:UZW
M3/)J<+Y?)IQJXFE;I"JO_;X2?XG5^$_^"8_[*_A:XANKG1/$_BZ2%T?R_%VN
M6E];2%,9$MGIND6$#JY!W#RP/F.W`Z<6,X^XCQ2E%5Z6%B^E"C&%O1R<W][;
M.BCP]EU"SM5J./\`/4?XJ/*OP/M[PCX&\&^`-*BT+P1X6T#PGH\`4)IWA_2K
M+2K7*C:'DCLX8_.EQUDDW,>Y-?)8C%8G%U'6Q5>=>H]Y3DV_E?9>2T/6I4*.
<'BH4*4:,%TBDOR.IP!VK"UMM#6UMD+0`4`?_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
